Anne Altmeyer, Ph.D., MBA, MPH
Board Member
Corbus Pharmaceuticals Holdings, Inc. (CRBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anne Altmeyer, Ph.D., MBA, MPH
Anne Altmeyer, Ph.D., MBA, MPH is recorded as Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed September 26, 2022 that Anne Altmeyer, Ph.D., MBA, MPH was appointed member of the Board, effective September 20, 2022.
“On September 20, 2022, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Anne Altmeyer, Ph.D., MBA, MPH, age 58, to serve as a member of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Corbus Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Yuval Cohen CEO, Board Member
- Alan Holmer Chairman, Board Member
- Sean Moran CFO
- Ian Hodgson COO
- Anne Altmeyer Board Member
- Avery W. Catlin Board Member
- Brent Pfeiffenberger Board Member
- George S. Golumbeski Board Member
- John Jenkins Board Member
- Rachelle Jacques Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.